INTRODUCTION

Renal Cell Cancer
Renal cell adenomas (RCA) and carcinomas (RCC) consti tute a heterogeneous group of tumors and this heterogene ity is a well-known complicating factor in the diagnosis. The histogenesis of renal cell cancer has been controver sial for a long time, especially in terms of the thesis origi nally expressed by Virchow and advocated by Grawitz [1] that certain clear cell epithelial renal tumors are derived from ectopic adrenocortical elements. This has led to the term "hyp er nephroma" or Grawitz tumor and finally also to the term "hypernephroid renal carcinoma." Although true hyperaephrogenic tumors do rarely occur in the kid ney, the hypernephrogenic theory of the clear cell epithe lial renal tumors has been questioned for a long time and preference is given instead to the renal tubular histogene sis. The evidence that the usual (nonembryonic) renal ade nomas and carcinomas in all their variants derive, in principle, from the mature uriniferous tubule has been promoted and consolidated by animal experiments with carcinogens and observation of prestages and early stages of epithelial renal tumors in hum an kidneys [2-4],
CLASSIFICATION OF RENAL CELL CANCER
The aim of a histopathologic classification is to use morpho logic criteria to identify biologically distinct disease states, the recognition of which are of clinical value [5], Therefore, modern tumor classifications generally are cyto logic ally ori entated, i.e., emphasizing histogenesis and differentiation. The formation of such a classification for epithelial renal tumors has proved difficult. Previous attempts have been "closed" systems using histology as the basis both for 'the classification and for the recognition of the distinct spe cies [5] .
Currently two morphologic classifications are used: one according to the WHO/AFIP [6] and one according to Thoenes et al. [7] and Störkel [8] , As stated in the latter, eight different subtypes of RCA/RCC can be distinguished, related to the basic cell types of the nephron from which they are derived: (1) RCCs of the clear cell type, (2) RCAs/ RCCs of the chromophilic cell type, (3) RCAs/RCCs of the chromophobic cell type, (4) RCCs of the duct Bellini cell type, (5) RCCs of the transitional cell type, (6) RCCs of the neuroendocrine type, (7) RCAs of the oncocytic type, and (8) RCAs of the metanephroid type, These types show phenotypical/histogenetical relations to different parts or cell types, respectively, of the nephron collecting duct system [8], Basically three growth patterns, which can be deduced from the tubule, are distinguished: (1) compact (subtype: aci nar); (2) tubulopapillary, and (3) cystic. Principally, in a given tumor, all growth patterns can occur simultaneously, but generally one of them predominates. There are relation ships to the cell types, although not exclusive: clear cell and chromophobe type are predominantly related to compact growth, chromophilic to tubulopapillary growth, oncocytic (true 'renal oncocytoma') is related to acinar, and Bellini duct to both compact and tubulopapillary growth. E. van den Berg et al.
The renal cell carcinomas are graded with respect to nu clear atypia, including the size of nucleoli, supplemented by cytoplasmic features, e.g. diminution of basic features, aug mentation of eos i no ph ilia/granularity (mitochondria), and spindle/pleomorphic cell form. Presently, according to these parameters three grades (Gl, G2, G3/4) are distinguished [7] , CYTOGENETIC AND MORPHOLOGIC CORRELATIONS Cytogenetics allows the classification of tumors with respect to their genotypic differences. Figure 1 summarizes and correlates both morphology and cytogenetic data with respect to histogenetic aspects of most of the basic tumor subtypes mentioned above. RCCs of the transitional cell type, neuroendocrine type, and RCAs of the metanephroid type are not mentioned in Figure 1 because of the limited data available.. One of the first genetic alterations in tumor development, associated with the epithelia of the proximal tubule, are trisomy 7 and loss of the Y chromosome, proba bly resulting in hyperplastic and dysplastic changes.
But trisomy 7 and loss of Y may have limited or no sig nificance with respect to RCC development and progres sion, because these chromosomal alterations have been demonstrated to be present in normal cells of tumor-adjacent kidney parenchyma rather than in the tumor itself [9] and trisomy 7 and trisomy 10 can be found in subpopula tions of tumor-infiltrating lymphocytes [10], Recently, oc currence of trisomies 5, 8, and 18 has also been reported for non-neoplastic kidney tissue [11, 12] . A gain of chromo some 7 may confer growth advantage to some malignant cells, because of the presence of the epidermal growth factor receptor on this chromosome [13] , The loss of one sex chromosome has been observed frequently. The nonrandom loss of the Y chromosome in RCC remains obscure and is possibly age-related [14, 15] . The most frequent find ing in RCCs of the clear cell type is a deletion or unbalanced translocation involving the short arm of chromosome 3 [16] [17] [18] .
The breakpoints appear to cluster in region 3pll-p21, usually at 3pl4. Involvement of the long arm has seldom been described. Recently, the relevant tumor suppressor gene responsible for the hereditary forms (von HippelLindau disease) has been identified [19] , This gene seems also to play a role in the development of the sporadic forms, probably in combination with other gene(s) [20, 21] . More over, a recent report suggests the presence of clear cell RCAs, showing only one deletion at 3p (3 p -in Fig, 1) , either 3pl4 or 3p25, whereas subsequent loss of the 3p21 region results in clear cell RCCs (3p= in Fig. 1 about papillary RCC showing rearrangement of the critical 3p segment, at least at a molecular level [33, 34] , Several hum an renal cell carcinomas with X;autosome translocations have been reported in recent years (see for review [35] ], The t(X;l)(pll.2;q21) appears to be a specific primary anomaly, suggesting that tumors with this translo cation form a distinct subgroup of chromophilic RCC, showing clear cell features. These tumors preferentially occur in male patients [36] [37] [38] [39] , although one female case has recently been described [40] .
Chromophobic carcinomas show multiple losses of entire chromosomes, i.e. loss of chromosomes 1, 2, 6, 10, 13, 17, 21, and the Y chromosome, leading to a low chromosome number. They also show quantitative as well as qualitative changes in mitochondrial DNA [41, 42] * Two reports with cytogenetica data from collecting duct carcinomas revealed conflicting findings of monosomy for chromosomes 1, 6, 14, 15, and 22 in one case [43] and trisomies 7, 12, 16, 17, and 20 in the other [44] , Schoenberg et al. [45] reported involvement of the short arm of chro mosome 8 related to poor prognosis and loss of the long arm of chromosome 13, both in three out of six cases.
There are no cytogenetic data on RCCs of the transitional cell type. Only one case with cytogenetics of RCC of the neuroendocrine type has been published revealing structural and numerical aberrations of chromosome 13 [46] . Molecu lar analysis of another case showed LOH on 3p21 [47] . Both transitional cell RCCs and neuroendocrine RCCs are not mentioned in Figure 1 . RCAs of the oncocytic type seem to be characterized by mitochondrial DNA changes [48, 49] , a feature they share with the chromophobic carcinomas, At least two subgroups can be distinguished: one character ized by translocations involving llq l3 [50] and one by the combination of -Y, -1 [51, 52] . Loss of chromosomes 1 and Y is also observed in chromophobic carcinomas, From a cytogenetic point of view, oncocytomas showing -Y, -1 might progress to chromophobic carcinomas through addi tional chromosome losses (see Figure 1 ]. This might explain why oncocytomas, which are considered to be benign neo plasms, occasionally show malignant behavior. One case of RCA of the metanephroid type (not mentioned in Figure  1 ) revealed a normal (46,XY) karyotype [53] .
A strong correlation between pronounced telomere shortening and the appearance of telomeric associations of chromosomes was found in three renal cell tumor subtypes (RCAs of the oncocytic type, RCAs/RCCs of the chromophobic type, and RCCs of the chromophilic type), sug gesting an etiologic role of the loss of telomeric DNA repeats in the formation of telomeric associations and a possible involvement of this mechanism in the pathogene sis of chromosome aberrations [54] .
CYTOGENETICS AND TUMOR PROGRESSION ; t
In the clear cell RCCs, monosomy 8, 9, 13, and 14, and trisomy of chromosomes 12 and 20 seem to correlate with a higher grade, and thus progression. Also structural aberra tions (and probably loss of heterozygosity) of chromosomes 5q, 6q, 8p, 9, lOq, and 14q are associated with tumor pro gression [18,55, own observations]. In RCAs/RCCs of the chromophilic type polysomies 12,16, and 20 are associated with progression from adenoma into carcinoma stage. The loss of the extra chromosome 17p in RCCs of the chro mophilic type tend to be related to the higher grade neo plasms, in which also a higher frequency of trisomy 20 is found [56] . It seem that tumors derived from the proximal tubule (RCAs/RCCs of the clear cell and the chromophilic cell type) share secondary karyotypic changes and this might suggest that many of the tumor suppressor loci involved may be common to the etiology of both forais [57] .
Sarcomatoid transformation in RCC represents the highest form of de differentiation [7] . Sarcomatoid variants of RCC can in principle be deduced from all the basic cell types. Cytogenetic data on sarcomatoid RCC is scarce. Grammatico et al. [58] reported a sole case of pleuric effusion of sarcomatoid RCC with structural abnormalities of chromo somes 1,5, 16,and 19. Others have found a relation between p53 mutations and sarcomatoid RCC [59] . Because it is not clear which basic cell types are involved in the above mentioned cases, these data are not included in Figure 1 .
CONCLUSION
Renal cell cancers (RCCs) are epithelial neoplasms that demonstrate a diversity of morphologic characteristics and clinical manifestations. The classification of the heteroge neous group of RCC is still a matter of debate.
Different subtypes of renal cell carcinoma might originate from cells of the different parts of the renal tubulus. Taken together, cytogenetic and molecular genetic studies of recent somal abnormalities correlate with different histologic subtypes of renal tumors. Chromosomal abnormalities are believed to be responsible for neoplastic transformation, tumor growth, and tumor progression [60] . Oncogenetic studies might reveal the cell of origin, oncogenetic steps, and relationship of tumors. The view of a relation between renal cell adenomas and carcinomas is strengthened by the fact that oncocytomas and adenomas occasionally show a malignant behavior. A reasonable explanation for this exceptional behavior is that oncocytomas and ade nomas probably represent the benign side of a spectrum of renal cell tumors, with renal cell carcinoma at the other extreme. If the "spectrum" concept for adenomas and car cinomas is correct, then it may be expected that there would also exist an overlap in some of the characteristics of these benign and malignant tumors. Referring to this concept, the chromophobic carcinoma could be the malig nant counterpart of the oncocytoma. Both show marker proteins and ultrastructural features of the distal nephron, thus disproving the broadly accepted hypothesis that all renal cell cancers are related to the proximal tubulus.
At the (cyto)genetic level, this oncogenetic sequence might be envisaged as depicted in Figure 1 , Thus, (cyto)genetic studies of renal cell adenomas, various subtypes of carcinomas, and oncocytomas will contribute to abetter understanding of the biology of these tumors, and reveal key information on the process of tu* morigenesis and tumor behavior. This information may open new opportunities for (early) diagnosis and specific therapy.
